Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the 403 error page, and the site revision label updates from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:19:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now shows site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-06T19:44:44.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study record content. The new page presents a minimal error screen with a Home link.
    Difference
    15%
    Check dated 2026-09-22T22:53:55.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision indicator on the page was updated from v3.6.6 to v3.7.0, signaling a platform update. This change affects only the version label and does not alter study information or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-15T20:52:42.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor backend/content-management update to the study page.
    Difference
    0.0%
    Check dated 2026-09-01T19:49:32.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.4 to v3.6.5 to reflect a newer page version. It represents an internal metadata update and does not change the study information presented.
    Difference
    0.0%
    Check dated 2026-08-11T18:22:42.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.